chlorothiazide sodium
- Product NDC
- 67457-263
- 11-digit product format
- 674570263
- Labeler code
- 67457
- Product ID
- 67457-263_32cf85b9-a7a2-49be-bd94-a4e6c408796a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- chlorothiazide sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA202493
- Marketing category
- ANDA
- Marketing start
- 2014-08-08
- Marketing end
- 2021-11-30
- Substance
- CHLOROTHIAZIDE SODIUM
- Active strength
- 500 mg/18mL
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-263-30 | 67457026330 | 1 VIAL in 1 CARTON (67457-263-30) > 18 mL in 1 VIAL | 1 vial | 2014-08-08 | 2021-11-30 | No | No | Current |